Sermorelin Injection
A growth hormone-releasing peptide that supports deeper sleep, faster recovery and lean muscle by working with your body's own rhythm.
Injection
from $179/mo
Injected under the skin · Twice a week
Research-stagePeptideGnRHFertility
Kisspeptin
A research-stage peptide hormone that signals the brain's GnRH neurons to release LH and FSH. Twice-weekly subcutaneous injections. Evidence is early; this is for patients interested in experimental treatment.
- Works upstream of GnRH—signals the control center of your own hormones
- May help maintain LH/FSH signaling in specific hypogonadal states
- Twice-weekly needle—less frequent than some peptide protocols
- Monthly$299/mo
- Every 3 months$717 billed up front$239/mo
- Every 6 monthsBest value$1,254 billed up front$209/mo
- Free, discreet shipping
- Licensed U.S. pharmacy
- Board-certified physicians
Disclaimer: Prescription products require an online evaluation with a licensed medical professional who will determine if a prescription is appropriate. Products are compounded by a licensed pharmacy. The FDA has not reviewed or approved compounded products for any use for safety, efficacy, or quality. Compounded medications are not FDA-approved brand-name products.
- How
- Injected under the skin
- How often
- Twice a week
- Each shipment
- 1 vial
- Strength
- 1 mg/mL
What is kisspeptin?
(KISS-pep-tin)
Kisspeptin is a 54-amino-acid peptide hormone discovered in 2003 that acts on the hypothalamus—the brain's hormone control center. It binds to kisspeptin receptors on GnRH neurons, the cells that release gonadotropin-releasing hormone (GnRH), which in turn tells the pituitary to release LH and FSH. These two pituitary hormones drive testosterone and sperm production in men, and estrogen and ovulation in women. Kisspeptin sits upstream of GnRH: it is a signal that says "activate the system." In some types of hypogonadism or low gonadotropin states, kisspeptin may help restart or support the axis. However, the clinical evidence for kisspeptin use in humans is still early—most data come from small trials or case reports, not large randomized studies. It is an experimental therapy.
What's in it
- KisspeptinSignals the reproductive hormones
2003
the year kisspeptin was first identified as a key GnRH regulator; human clinical use remains research-stage, with limited published data
Kisspeptin is not FDA-approved for any indication. It is compounded and prescribed off-label at your physician's discretion for research and compassionate use.
Is it right for you?
Who it's for
Adults with low libido who want to work on the body's own hormone signal.
What sets it apart
It sits at the very top of the reproductive hormone chain, above LH and FSH.
Worth knowing before you start
It does little while you take testosterone, which switches that chain off.
Early observations
LH and FSH may rise
seen in published case reports but not guaranteed in every patient
Energy and mood
some patients report changes; others do not
Fertility potential
kisspeptin's mechanism may support sperm or egg production, but evidence is preliminary
How kisspeptin therapy works
Day 1
A US-licensed physician reviews your hypogonadal state, your history, labs (LH, FSH, testosterone), and goals. You discuss that kisspeptin is experimental and the evidence is limited. Your first supply ships discreetly to your door.
1Week 1
Subcutaneous injection of 0.1 mg (10 units) twice weekly. You may feel injection-site reactions (redness, minor swelling) or mild systemic effects (headache, flushing).
2Week 2–4
Your physician checks labs (LH, FSH, testosterone) to see if the axis is responding. Not all patients show a response; the evidence suggests response rates vary.
3Month 2–3
Your physician reviews your symptom change (energy, mood, sexual function, testicular size if applicable), lab response, and any side effects, and decides whether to continue, adjust, or stop.
4Beyond
Kisspeptin therapy is reassessed monthly. Your physician monitors labs and symptoms and reviews the risk-benefit balance with you, as long-term safety data remain limited.
5
Individual results vary. Benefits reflect what Zepym Health members commonly report to their physician at check-ins; they are not the results of a clinical trial.
How you use it
This is the starting dose the pharmacy prints on the label. Your physician sets yours and adjusts it with you.
- How
- Injected under the skin
- Dose
- 10 units (0.1 mg)
- How often
- Twice a week
- Each shipment
- 1 vial
- Pharmacy label
- Inject 10 units (0.1 mg) subcutaneously twice weekly for 4 weeks. Discard any remaining medication.
A sample week
- M
- T
- W
- T
- F
- S
- S
Twice a week
The science of kisspeptin in research
Kisspeptin's role in GnRH signaling is well established in animal models and molecular biology. In humans, kisspeptin signaling defects cause rare forms of hypogonadotropic hypogonadism. Some small studies suggest kisspeptin injections may stimulate LH and FSH release and possibly help restore fertility in selected men.
Clinical evidence in humans is limited. Most published reports involve small numbers of patients with specific diagnoses (hypogonadotropic hypogonadism, Kallmann syndrome). Use in other contexts is anecdotal. Larger, controlled trials are needed to establish efficacy and safety in broader populations.
Learn moreImportant safety information and common side effects
Kisspeptin is an experimental therapy with a limited clinical evidence base in humans. Common effects from small studies include injection-site reactions (redness, swelling, itching), headache, flushing, nausea, and, in men, transient elevations of LH and FSH. Because kisspeptin acts on the hypothalamus and pituitary, it is not prescribed with a pituitary tumor or a hormone-sensitive cancer (prostate, breast). Pregnancy is a contraindication. The long-term effects of kisspeptin therapy in humans are not well characterized—most published experience spans weeks to a few months. Off-label use in hypogonadism rests on physiology and small case series, not large randomized trials. You should be fully informed that kisspeptin is experimental and that you are essentially participating in extended observation. Tell your physician about every medication and supplement you take. Stop and seek care for chest pain, severe headache, vision changes, or signs of pituitary dysfunction (extreme fatigue, weakness, low blood pressure, nausea).
Every plan includes
- Personalized, physician-guided plan
- Monthly, 3-month and 6-month plans
- Dispensed by a US-licensed compounding pharmacy
- Unlimited protocol adjustments and messaging
- Ongoing support and check-ins
- Pause or cancel anytime
- Reviewed by our in-house physicians
How it works
1.Connect with a physician
Answer a few questions online and a US-licensed physician reviews your health, history and goals to make sure treatment is right for you. 100% online. No in-person visit required.
2.Get your discreet shipment
If approved, your treatment is compounded by a US-licensed, LegitScript-certified pharmacy, inspected for quality, and shipped discreetly to your door.
3.Receive continuous support
Start with one goal, then keep building over time. Unlimited physician messaging, easy refills and dose adjustments, all from the Zepym Health app.
Kisspeptin educational content reviewed by our physician
Scott Nass, MDDoctor of Medicine, board-certified in Family Medicine
Charles R. Drew University and David Geffen School of Medicine at UCLA. Family Medicine residency at Ventura County Medical Center.
Frequently asked questions
How do I use Kisspeptin?
Injected under the skin, twice a week. The starting prescription is 10 units (0.1 mg) each time. Your physician sets your own dose and it is printed on your label.
How much arrives in each shipment?
1 vial at the starting strength, shipped to your door from a licensed US pharmacy.
Is kisspeptin approved by the FDA?
No. Kisspeptin is not FDA-approved for any indication. It is compounded by licensed pharmacies and prescribed off-label at your physician's discretion, typically for research purposes or compassionate use in specific hypogonadal states. You should understand that evidence in humans is limited.
Why is kisspeptin experimental?
Because clinical data in humans are limited. Kisspeptin's role in the hypothalamus is well proven in science, but only small case series and a handful of small trials have tested it in humans with hypogonadism. Larger, controlled studies are needed to know how well it works and what its full safety profile is.
Will it definitely restore my fertility?
Not necessarily. Kisspeptin may help restore LH and FSH signaling in some hypogonadal states, which could support sperm or egg production, but published response rates vary. Some men on kisspeptin show improved sperm counts; others do not. Your physician will monitor labs.
What if kisspeptin doesn't work for me?
Your physician will reassess after a trial period—usually 8–12 weeks. If labs show no LH/FSH response or you have no symptom improvement, your physician may recommend stopping and returning to other options or observation. There is no obligation to continue an ineffective therapy.
GnRH signaling, explored.
Tesamorelin
A peptide that targets stubborn abdominal fat and supports a leaner body composition, prescribed and monitored by a licensed clinician.
Injection
from $179/mo
Sermorelin Troches
The same growth hormone-releasing peptide as a dissolving troche, for people who would rather skip injections.
Troche
from $179/mo
CJC-1295 / Ipamorelin
Two peptides that prompt your pituitary to release your own growth hormone, used for deeper sleep, recovery and body composition. Prescribed and dosed by a licensed physician.
Injection
from $229/mo
The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Prescription products require an online evaluation with a licensed medical professional who will determine if a prescription is appropriate. Individual results vary.
Sources
- 1
The GPR54 gene as a regulator of puberty.
N Engl J Med, 2003 - 2
The neuroendocrine physiology of kisspeptin in the human.
Rev Endocr Metab Disord, 2007 - 3
Kisspeptin and neurokinin B: roles in reproductive health.
Physiol Rev, 2025
Kisspeptinfrom $209/mo